Piper Sandler Reiterates Overweight on Doximity, Raises Price Target to $47
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsReiterationPrice Target
Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE:DOCS) with a Overweight and raises the price target from $42 to $47.
Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE:DOCS) with a Overweight and raises the price target from $42 to $47.